Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | MPO | P05164 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29681353 | 1.00 | TDP1 (0.43) | TDP1POLBKDM4ELTA4HEPHX2 | |
| SCHEMBL29681348 | 1.00 | TDP1 (0.43) | TDP1POLBKDM4ELTA4HEPHX2 | |
| SCHEMBL27292 | 0.92 | CYP4F2 (0.49) | TDP1POLBKDM4ELTA4HEPHX2 | |
| SCHEMBL9672220 | 0.92 | LIPG (0.43) | TDP1POLBKDM4ELIPGCYP4F2 | |
| SCHEMBL30750761 | 0.92 | LIPG (0.43) | TDP1POLBKDM4ELIPGCYP4F2 | |
| SCHEMBL2178352 | 0.89 | LIPG (0.47) | TDP1POLBLIPGCYP4F2CYP4A11 | |
| SCHEMBL12634509 | 0.88 | LIPG (0.52) | LIPGCYP4F2CYP4A11 | |
| SCHEMBL13552185 | 0.88 | LIPG (0.47) | POLBKDM4ELIPGCYP4F2CYP4A11 | |
| SCHEMBL5629736 | 0.88 | DPP4 (0.45) | TDP1POLBKDM4ELTA4HEPHX2 | |
| SCHEMBL1150835 | 0.88 | CYP4A11 (0.46) | POLBKDM4ELIPGCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1028132-A1 | Process for preparing thermoplastic polyurethanes | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-16 | — | — | EP | claimed |
| EP-4003314-B1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS INC (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-111491891-B | EMM-31 material, method and use thereof | 埃克森美孚科技工程公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20230007838-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. | 2023-01-12 | — | — | US | disclosed |
| US-20220402851-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. | 2022-12-22 | — | — | US | disclosed |
| US-11084773-B1 | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease | ESPERVITA THERAPEUTICS, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| US-20210221765-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. | 2021-07-22 | — | — | US | disclosed |
| WO-2021021563-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. (US) | 2021-02-04 | — | — | WO | disclosed |
| US-20210024447-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. | 2021-01-28 | — | — | US | disclosed |
| EP-3728119-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | ExxonMobil Research and Engineering Company (US) | 2020-10-28 | — | — | EP | disclosed |
| US-4517327-A | AMINO RESIN, STYRENE-(METH)ALLYL ALCOHOL COMPOLYER, ACRYLIC OR POLYESTER RESIN | MONSANTO COMPANY (US) | 1985-05-14 | — | — | US | disclosed |
| US-4299743-A | Sulfonate-containing polymer | PPG INDUSTRIES, INC. (US) | 1981-11-10 | — | — | US | disclosed |
| US-4293398-A | Process for cathodically electrodepositing polymers having tertiary amine oxide groups | PPG INDUSTRIES, INC. (US) | 1981-10-06 | — | — | US | disclosed |
| US-4218355-A | Low organic solvent-containing polyester coating compositions | PPG INDUSTRIES, INC. (US) | 1980-08-19 | — | — | US | disclosed |
| US-4204010-A | Radiation curable, ethylenically unsaturated thixotropic agent and method of preparation | W. R. GRACE & CO. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4031290-A | ALPHA-BETA MONOMERS, CATALYSIS | PPG INDUSTRIES, INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-4025474-A | AUTOMOTIVE FINISHING | PPG INDUSTRIES, INC. (US) | 1977-05-24 | — | — | US | disclosed |
| US-4016332-A | OF ETHYLENICALLY UNSATURATED MONOMERS | PPG INDUSTRIES, INC. (US) | 1977-04-05 | — | — | US | disclosed |
| US-3994851-A | AMINE-ALDEHYDE CROSSLINKING AGENT | PPG INDUSTRIES, INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3933940-A | Mercaptan blocked thermosetting copolymers | PPG INDUSTRIES, INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230007838-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | CPT1A, PPARG, PC | TDP1 4828/4885POLB 2084/4885KDM4E 2762/4885 |
| US-20210221765-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | CPT1A, PPARG, PC | TDP1 4830/4885POLB 2088/4885KDM4E 2757/4885 |
| US-11084773-B1 | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease | CPT1A, PPARG, PC | TDP1 4830/4885POLB 2088/4885KDM4E 2757/4885 |
| US-20210024447-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | CPT1A, PPARG, PC | TDP1 4830/4885POLB 2088/4885KDM4E 2757/4885 |
| US-20220402851-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | CPT1A, PPARG, PC | TDP1 4828/4885POLB 2084/4885KDM4E 2762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.